{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:00:13Z","timestamp":1782536413876,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grant Commission, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejmech.2017.12.049","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T08:47:27Z","timestamp":1513327647000},"page":"544-556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX"],"prefix":"10.1016","volume":"144","author":[{"given":"Mohammad Fawad","family":"Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Avecilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.12.049_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2017.12.049_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1677\/erc.0.0080161","article-title":"Receptor tyrosine kinase signalling as a target for cancer intervention strategies","volume":"8","author":"Zwick","year":"2001","journal-title":"Endocr. Relat. Canc."},{"issue":"6","key":"10.1016\/j.ejmech.2017.12.049_bib3","first-page":"622","article-title":"The National Cancer Institute: cancer drug discovery and development program","volume":"19","author":"Grever","year":"1992","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejmech.2017.12.049_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/srep46356","article-title":"Synthesis and biological evaluation of 2-methyl-4, 5-disubstituted oxazoles as a novel class of highly potent antitubulin agents","volume":"7","author":"Romagnoli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2017.12.049_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.33786\/JCPR.2011.v01i04.010","article-title":"Pyrazole: their chemistry and pharmacological potentials: a review","volume":"1","author":"Dewangan","year":"2011","journal-title":"Curr. Pharma Res."},{"key":"10.1016\/j.ejmech.2017.12.049_bib6","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.bmc.2017.01.047","article-title":"Design, synthesis and biological evaluation of 2, 4-disubstituted oxazole derivatives as potential PDE4 inhibitors","volume":"25","author":"Li","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib7","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1016\/j.bmcl.2015.06.091","article-title":"Metronidazole hydrazone conjugates: design, synthesis, antiamoebic and molecular docking studies","volume":"25","author":"Ansari","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2017.12.049_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.saa.2015.07.057","article-title":"Synthesis, crystal structure, biological activity and theoretical calculations of novel isoxazole derivatives","volume":"152","author":"Jin","year":"2016","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejmech.2017.12.049_bib9","first-page":"392","article-title":"Synthesis, characterization and comparative study the microbial activity of some heterocyclic compounds containing oxazole and benzothiazole moieties","volume":"19","author":"Tomi","year":"2015","journal-title":"J.\u00a0Serb. Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.12.049_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ejmech.2014.10.058","article-title":"Bioactive thiazole and benzothiazole derivatives","volume":"97","author":"Rouf","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1021\/jm401546n","article-title":"Discovery of 1-Methyl-1 H-imidazole derivatives as potent Jak2 inhibitors","volume":"57","author":"Su","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm980363y","article-title":"Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists","volume":"42","author":"Lan","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib13","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1021\/jm020557k","article-title":"Pyrazole and isoxazole derivatives as new, potent, and selective 20-hydroxy-5, 8, 11, 14-eicosatetraenoic acid synthase inhibitors","volume":"46","author":"Nakamura","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsps.2010.05.002","article-title":"Synthesis and antimicrobial activity of new 4-thiazolidinone derivatives containing 2-amino-6-methoxybenzothiazole","volume":"18","author":"Patel","year":"2010","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.ejmech.2017.12.049_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2013.04.010","article-title":"Synthesis and biological evaluation of novel thiazolidinone derivatives as potential anti-inflammatory agents","volume":"64","author":"Hu","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bmc.2009.10.041","article-title":"Novel 4-thiazolidinone derivatives as potential antifungal and antibacterial drugs","volume":"18","author":"Omar","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib17","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1016\/j.bmc.2011.06.025","article-title":"Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds","volume":"19","author":"Ruiz","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib18","first-page":"58","article-title":"Synthesis and anticonvulsant activity of clubbed thiazolidinone\u2013barbituric acid and thiazolidinone\u2013triazole derivatives","volume":"14","author":"Shiradkar","year":"2007","journal-title":"Arvicola"},{"key":"10.1016\/j.ejmech.2017.12.049_bib19","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.ejmech.2008.05.036","article-title":"Predicting anti-HIV activity of 1, 3, 4-thiazolidinone derivatives: 3D-QSAR approach","volume":"44","author":"Ravichandran","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib20","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/j.ejmech.2011.03.068","article-title":"Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications","volume":"46","author":"Ottan\u00e0","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib21","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1016\/j.bmc.2012.03.069","article-title":"Recent developments and biological activities of thiazolidinone derivatives: a review","volume":"20","author":"Jain","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib22","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1016\/j.ejmech.2010.08.008","article-title":"Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety","volume":"45","author":"Havrylyuk","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib23","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1016\/j.ejmech.2011.05.017","article-title":"Design, synthesis and biological evaluation of novel 4-thiazolidinones containing indolin-2-one moiety as potential antitumor agent","volume":"46","author":"Wang","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejmech.2013.02.030","article-title":"Anticancer activity of novel hybrid molecules containing 5-benzylidene thiazolidine-2, 4-dione","volume":"63","author":"Romagnoli","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejmech.2013.05.044","article-title":"Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones","volume":"66","author":"Havrylyuk","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib26","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1021\/jm300789g","article-title":"Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity","volume":"55","author":"Havrylyuk","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2014.04.068","article-title":"Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents","volume":"80","author":"Wu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib28","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1016\/j.bmcl.2015.06.069","article-title":"Antiproliferative and tumor inhibitory studies of 2, 3 disubstituted 4-thiazolidinone derivatives","volume":"25","author":"Kumar","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2017.12.049_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejmech.2016.03.089","article-title":"5-Ene-4-thiazolidinones induce apoptosis in mammalian leukemia cells","volume":"117","author":"Senkiv","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib30","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1016\/j.bmcl.2016.08.013","article-title":"Synthesis and biological evaluation of novel 2-imino-4-thiazolidinone derivatives as potent anti-cancer agents","volume":"26","author":"Appalanaidu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2017.12.049_bib31","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/j.bmcl.2005.05.034","article-title":"Rhodanine derivatives as inhibitors of JSP-1","volume":"15","author":"Cutshall","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2017.12.049_bib32","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.bmcl.2006.02.060","article-title":"Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors","volume":"16","author":"Ahn","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2017.12.049_bib33","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.bmcl.2008.03.013","article-title":"Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening","volume":"18","author":"Park","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2017.12.049_bib34","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1021\/jm8004306","article-title":"2-Thiazolylimino\/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action","volume":"51","author":"Geronikaki","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib35","doi-asserted-by":"crossref","first-page":"11879","DOI":"10.1073\/pnas.211178398","article-title":"Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-\u03b1","volume":"98","author":"Carter","year":"2001","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2017.12.049_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/35055085","article-title":"Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL","volume":"3","author":"Degterev","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2017.12.049_bib37","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1021\/jm051296s","article-title":"Discovery of small molecule integrin \u03b1v\u03b23 antagonists as novel anticancer agents","volume":"49","author":"Dayam","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib38","doi-asserted-by":"crossref","unstructured":"Jemmezi, F., Kether, F.B.H., Amri, I., Bassem, J. and eddine Khiari, J. Synthesis and biological activity of novel benzothiazole pyridine derivatives. IOSR JAC. 7, 62\u201366.","DOI":"10.9790\/5736-07116266"},{"key":"10.1016\/j.ejmech.2017.12.049_bib39","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejmech.2014.03.018","article-title":"Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids","volume":"77","author":"Nepali","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib40","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1016\/j.bmc.2012.03.069","article-title":"Recent developments and biological activities of thiazolidinone derivatives: a review","volume":"20","author":"Jain","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib41","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00044-011-9751-9","article-title":"Synthesis of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety for evaluation as anticancer and radiosensitizing agents","volume":"21","author":"El Ella","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2017.12.049_bib42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2017.07.073","article-title":"Novel 4\/3-((4-oxo-5-(2-oxoindolin-3-ylidene) thiazolidin-2-ylidene) amino) benzenesulfonamides: synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies","volume":"139","author":"Eldehna","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib43","first-page":"221","article-title":"Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases subcell","volume":"75","author":"Narges","year":"2014","journal-title":"Biochemist"},{"key":"10.1016\/j.ejmech.2017.12.049_bib44","first-page":"400","article-title":"Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors","volume":"4","author":"Sedlakova","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejmech.2017.12.049_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2867-13-89","article-title":"Acidic extracellular microenvironment and cancer","volume":"13","author":"Kato","year":"2013","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.ejmech.2017.12.049_bib46","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ijc.23496","article-title":"CAIX and VHL status define two types of clear cell renal cell carcinoma: low CAIX expression and absence of VHL gene mutation are associated with tumour aggressiveness and poor survival","volume":"123","author":"Patard","year":"2008","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejmech.2017.12.049_bib47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jinorgbio.2015.06.015","article-title":"The key role of coligands in novel ruthenium (II)-cyclopentadienyl bipyridine derivatives: ranging from non-cytotoxic to highly cytotoxic compounds","volume":"150","author":"C\u00f4rte-Real","year":"2015","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib48","doi-asserted-by":"crossref","first-page":"o914","DOI":"10.1107\/S1600536811009603","article-title":"N-[2-(4-Bromophenyl)-5-methyl-4-oxo-1, 3-thiazolidin-3-yl] pyridine-3-carboxamide","volume":"67","author":"Akkurt","year":"2011","journal-title":"Acta Crystallogr. E"},{"key":"10.1016\/j.ejmech.2017.12.049_bib49","first-page":"89","article-title":"Potential anticancer compound from Cerbera odollam","author":"Syarifah","year":"2011","journal-title":"J.\u00a0Trop. For. Sci."},{"key":"10.1016\/j.ejmech.2017.12.049_bib50","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1200\/JCO.2000.18.3.562","article-title":"Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients","volume":"18","author":"Alexandre","year":"2000","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ejmech.2017.12.049_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/13880200600592301","article-title":"Selective anticancer activity of pure licamichauxiioic-B acid in cultured cell lines","volume":"44","author":"Badisa","year":"2006","journal-title":"Pharmaceut. Biol."},{"key":"10.1016\/j.ejmech.2017.12.049_bib52","first-page":"17","article-title":"Receptor chemoprint derived pharmacophore model for development of CAIX inhibitors","volume":"8","author":"Amresh","year":"2013","journal-title":"J.\u00a0Carcinog. Mutagen. S"},{"key":"10.1016\/j.ejmech.2017.12.049_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jmgm.2016.01.006","article-title":"Design and synthesis of a novel class of carbonic anhydrase-IX inhibitor 1-(3-(phenyl\/4-fluorophenyl)-7-imino-3H-[1, 2, 3] triazolo [4, 5d] pyrimidin 6 (7H) yl) urea","volume":"64","author":"Kumari","year":"2016","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2017.12.049_bib54","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/jcc.21478","article-title":"A\u00a0new Lamarckian genetic algorithm for flexible ligand-receptor docking","volume":"31","author":"Fuhrmann","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib55","series-title":"SADABS, Version 2.10","author":"Sheldrick","year":"2004"},{"key":"10.1016\/j.ejmech.2017.12.049_bib56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","volume":"64","author":"Sheldrick","year":"2008","journal-title":"SHELX, Acta Crystallogr., Sect. A"},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2017.12.049_bib57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Meth."},{"key":"10.1016\/j.ejmech.2017.12.049_bib58","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2017.12.049_bib59","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/1570180814666161214114322","article-title":"Pharmacokinetic evaluation of callistemon viminalis derived natural compounds as targeted inhibitors against \u03b4-opioid receptor and farnesyl transferase","volume":"14","author":"Ahmad","year":"2017","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2017.12.049_bib60","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejmech.2016.08.053","article-title":"Synthesis, antiamoebic and molecular docking studies of furan-thiazolidinone hybrids","volume":"124","author":"Ansari","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.12.049_bib62","doi-asserted-by":"crossref","first-page":"90371","DOI":"10.1039\/C6RA15181G","article-title":"Thienopyrimidine sulphonamide hybrids: design, synthesis, antiprotozoal activity and molecular docking studies","volume":"6","author":"Zaidi","year":"2016","journal-title":"RSC Adv."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417310814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417310814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T21:06:18Z","timestamp":1751144778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417310814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":62,"alternative-id":["S0223523417310814"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.12.049","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.12.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}